| Menopause |
1 |
1 |
| Testosterone |
0 |
0.99 |
| Low Testosterone |
0 |
0.72 |
| Testosterone Therapy |
0 |
0.98 |
| Hypoactive Sexual Desire Disorder |
0 |
0.43 |
| Fractures |
0 |
0.37 |
| Healthcare and Medical Technology |
0 |
0.32 |
| Hypogonadism |
0 |
0.32 |
| Skin and Soft Tissue Infection |
0 |
0.26 |
| Osteoporosis |
0 |
0.23 |
| Depression |
0 |
0.22 |
| Patient Safety |
0 |
0.22 |
| Thromboembolism |
0 |
0.18 |
| Muscle |
0 |
0.16 |
| Acne |
0 |
0.11 |
| Cerebrovascular Accident |
0 |
0.11 |
| Ethics |
0 |
0.11 |
| Bone Density |
0 |
0.09 |
| Blood |
0 |
0.08 |
| Bone |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Endocrine Society |
0 |
0.08 |
| Leukemia |
0 |
0.08 |
| Thrombus |
0 |
0.08 |
| Adverse Effects |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Estrogen |
0 |
0.06 |
| Hair |
0 |
0.06 |
| Hair Growth |
0 |
0.06 |
| Hip Fracture |
0 |
0.06 |
| Plantar |
0 |
0.06 |